Development of cochlear sensitivity to aminoglycoside antibiotics

Annals of Otology, Rhinology and Laryngology

Volumn 107, Issue 3, 1998, Pages 220-226

  O'Leary, Stephen J ^b   Moore, David R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Auditory brain stem response; Deafness; Ototoxicity; Rat

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; FUROSEMIDE; GENTAMICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY THRESHOLD; COCHLEA; CONTROLLED STUDY; DOSE RESPONSE; EVOKED BRAIN STEM AUDITORY RESPONSE; HEARING IMPAIRMENT; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; OTOTOXICITY; PERINATAL PERIOD; PRIORITY JOURNAL; RAT;

EID: 0031969265     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949810700306     Document Type: Article

References (42)

1. Onejeme AU, Khan KM. Morphologic study of effects of kanamycin on the developing cochlea of the rat. Teratology 1984;29:57-71.
2. Pierson MG, Swann JW. The sensitive period and optimum dosage for induction of audiogenic seizure susceptibility by kanamycin in the Wistar rat. Hear Res 1988;32:1-10.
3. Lenoir M, Marot M, Uziel A. Comparative ototoxicity of four aminoglycosidic antibiotics during the critical period of cochlear development in the rat. A functional and structural study. Acta Otolaryngol Suppl (Stockh) 1983(suppl 405).
4. Osako S, Tokimoto T, Matsuura S. Effects of kanamycin on the auditory evoked responses during postnatal development of the hearing of the rat. Acta Otolaryngol (Stockh) 1979;88:359-68.
5. Chen CS, Saunders JC. The sensitive period for ototoxicity of kanamycin in mice: morphological evidence. Arch Otorhinolaryngol 1983;238:217-23.
6. Prieve BA, Yanz JL. Age-dependent changes in susceptibility to ototoxic hearing loss. Acta Otolaryngol (Stockh) 1984;98:428-38.
7. Salvi RJ, Saunders SS, Hashino E, Chen L. Discharge patterns of chicken cochlear ganglion neurons following kanamycin-induced hair cell loss and regeneration. J Comp Physiol [A] 1994;174:351-69.
8. Fikes JD, Render JA, Reed WM, Bursian S, Poppenga RH, Sleight SD. Insensitivity of the chicken embryo to the ototoxicity of aminoglycoside antibiotics and a loop diuretic. Toxicol Pathol 1994;22:10-4.
9. Dumas G, Charachon R. Ototoxicity of kanamycin in developing guinea pigs. An electrophysiological study. Acta Otolaryngol (Stockh) 1982;94:203-12.
10. Johansson B, Wedenberg E, Westin B. Fetal heart rate response to acoustic stimulation in relation to fetal development and hearing impairment. Acta Obstet Gynecol Scand 1992;71: 610-5.
11. Hepper PG, Shahidullah BS. Development of fetal hearing. Arch Dis Child 1994;71:F81-F87.
12. Henderson-Smart DJ, Pettigrew AG, Edwards DA, Jiang ZD. Brain stem auditory evoked potentials: physiological and clinical issues. In: Hanson MA, ed. The fetal and neonatal brain stem. Cambridge, England: Cambridge University Press, 1991:211-29.
13. Moore DR, Rogers NJ, O'Leary SJ. Loss of cochlear nucleus neurons following aminoglycoside antibiotics or cochlear removal. Ann Otol Rhinol Laryngol 1998 (in press).
14. Wada T. Anatomical and physiological studies on the growth of the inner ear of the albino rat. Am Anat Memoirs 1923;10:1-74.
15. Kuijpers W. Na-K-ATPase activity in the cochlea of the rat during development. Acta Otolaryngol (Stockh) 1974;78:341-4.
16. Bosher SK, Warren RL. A study of the electrochemistry and osmotic relationships of the cochlear fluids in the neonatal rat at the time of the development of the endocochlear potential. J Physiol (Lond) 1971;212:739-61.
17. Schmidt RS, Fernandez C. Development of mammalian endocochlear potential. J Exp Zool 1963;153:227-36.
18. Uziel A, Romand R, Marot M. Development of cochlear potentials in rats. Audiology 1981;20:89-100.
19. Jewett DL, Romano MN. Neonatal development of auditory system potentials averaged from the scalp of rat and cat. Brain Res 1972;36:101-15.
20. Brummett RE, Bendrick T, Himes D. Comparative ototoxicity of bumetanide and furosemide when used in combination with kanamycin. J Clin Pharmacol 1981;21:628-36.
21. Brummett RE, Brown RT, Himes DL. Quantitative relationships of the ototoxic interaction of kanamycin and ethacry- nic acid. Arch Otolaryngol 1979;105:240-6.
22. Russell NJ, Fox KE, Brummett RE. Ototoxic effects of the interaction between kanamycin and ethacrynic acid. Cochlear ultrastructure correlated with cochlear potentials and kanamycin levels. Acta Otolaryngol (Stockh) 1979;88:369-81.
23. Yamane H, Nakai Y, Konishi K. Furosemide-induced alteration of drug pathway to cochlea. Acta Otolaryngol Suppl (Stockh) 1988(suppl 447):28-35,
24. Richardson GP, Russell IJ. Cochlear cultures as a model system for studying aminoglycoside induced ototoxicity. Hear Res 1991;53:293-311.
25. Prieve BA, Yanz JL. Age-dependent changes in susceptibility to ototoxic hearing loss. Acta Otolaryngol (Stockh) 1984;98:428-38,
26. Shepherd RK, Martin RL. Onset of ototoxicity in the cat is related to onset of auditory function. Hear Res 1995;92:131-42.
27. Shepherd RK, Martin RL, Clark GM. Onset of ototoxicity in the cat is related to the onset of auditory function [Abstract]. Proc Aust Neurosci Soc 1993;4:112.
28. O'Leary SJ, Moore DR. Ototoxicity in neonatal rats to single dose gentamicin/frusemide [Abstract). Soc Neurosci Abs 1992;18:55.
29. Morey AL, Carlile S. Auditory brainstem of the ferret: maturation of the brainstem auditory evoked response. Dev Brain Res 1990;52:279-88.
30. Moore DR, Hine JE. Rapid development of the auditory brainstem response threshold in individual ferrets. Dev Brain Res 1992;66:229-35.
31. Xu SA, Shepherd RK, Chen Y, Clark GM. Profound hearing loss in the cat following the single co-administration of kanamycin and ethacrynic acid. Hear Res 1993;70:205-15.
32. Komune S, Snow JB Jr. Ototoxicity of kanamycin sulfate and the barriers in the inner ear. Arch Otolaryngol 1981;89:1013-8.
33. Dallos P. Cochlear potentials and cochlear mechanics. In: Møller A, ed. Basic mechanisms in hearing. New York, NY: Academic Press, 1973:335-72.
34. Fikes JD, Render JA, Reed WM, et al. Distribution of gentamicin to the cochlea of the chicken embryo. Toxicol Pathol 1994;22:15-22.
35. Schacht J. Molecular mechanisms of drug-induced hearing loss. Hear Res 1986;22:297-304.
36. Lenoir M, Puel J-L, Pujol R. Stereocilia and tectorial membrane development in the rat cochlea. Anal Embryol (Berl) 1987;175:477-87.
37. Rübsamen R. Postnatal development of central auditory frequency maps. J Comp Physiol [A] 1992;170:129-43.
38. Kotecha B, Richardson GP. Ototoxicity in vitro: effects of neomycin, gentamicin, dihydrostreptomycin, amikacin, spectinomycin, neamine, spermine and poly-L-lysine. Hear Res 1994;73:173-84.
39. Henley CM. Postnatal developmental changes in inner ear ornithine decarboxylase (ODC). Hear Res 1991;55:45-9.
40. Coling DE, Schacht J. Protein phosphorylation in the organ of Corti: differential regulation by second messengers between base and apex. Hear Res 1991;57:113-20.
41. Hayashida T, Hiel H, Dulon D, Erre JP, Guilhaume A, Aran JM. Dynamic changes following combined treatment with gentamicin and ethacrynic acid with and without acoustic stimulation. Cellular uptake and functional correlates. Acta Otolaryngol (Stockh) 1989;108:404-13.
42. Pettigrew AG, Edwards DA, Henderson-Smart DJ. Perinatal risk factors in preterm infants with moderate-to-profound hearing deficits. Med J Aust 1988;148:174-7.